CCL20 Protein (AA 27-96) (His tag)
-
- Target See all CCL20 Proteins
- CCL20 (Chemokine (C-C Motif) Ligand 20 (CCL20))
- Protein Type
- Recombinant
- Protein Characteristics
- AA 27-96
-
Origin
- Human
-
Source
- Escherichia coli (E. coli)
- Purification tag / Conjugate
- This CCL20 protein is labelled with His tag.
- Application
- SDS-PAGE (SDS)
- Characteristics
- CCL20, 27-96aa, Human, His tag, E.coli
- Purity
- > 85 % by SDS - PAGE
- Top Product
- Discover our top product CCL20 Protein
-
-
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.25 mg/ml (determined by Bradford assay)
- Buffer
- Liquid. In Phosphate Buffered Saline pH7.4 containing 10% glycerol
- Storage
- 4 °C
-
- Target
- CCL20 (Chemokine (C-C Motif) Ligand 20 (CCL20))
- Alternative Name
- CCL20 (CCL20 Products)
- Synonyms
- MIP-3ALPHA Protein, CCL20 Protein, si:dkey-150o13.1 Protein, CKb4 Protein, LARC Protein, MIP-3-alpha Protein, MIP-3a Protein, MIP3A Protein, SCYA20 Protein, ST38 Protein, MIP-3A Protein, MIP-3[a] Protein, Scya20 Protein, exodus-1 Protein, C-C motif chemokine ligand 20 Protein, chemokine (C-C motif) ligand 20b Protein, chemokine (C-C motif) ligand 20 Protein, CCL20 Protein, ccl20b Protein, Ccl20 Protein
- Background
- CCL20, also known as Macrophage Inflammatory Protein-3 (MIP3A), is a small cytokine belonging to the CC chemokine family. CCL20 protein is strongly chemotactic for lymphocytes and weakly attracts neutrophils. It is implicated in the formation and function of mucosal lymphoid tissues via chemoattraction of lymphocytes and dendritic cells towards the epithelial cells surrounding these tissues. Recombinant human CCL20 protein, fused to His-tag at N-terminus, was expressed in E.coli and purifed by conventional chromatography, after refolding of the isolated inclusion bodies in a renaturation buffer. Synonyms: C-C motif chemokine 20, CKb4, LARC, MIP-3a, MIP3A, SCYA20, ST38. NCBI no.: NP_004582
- Molecular Weight
- 10.3 kDa (91aa), confirmed by MALDI-TOF
- Pathways
- The Global Phosphorylation Landscape of SARS-CoV-2 Infection
-